Schedule 13G ownership disclosure

ORIC Pharmaceuticals Inc

Security class unavailable · CUSIP: 68622P109

Event date: 2020-11-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.6700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-121611
Form type
SC 13G/A
Filer
Oric Pharmaceuticals, Inc.
CIK
CIK 1796280
Filed
Nov 05, 2020
Reporting period
Nov 04, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub